Advances in the available pharmacotherapy for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

A Greco, S Finocchiaro, DJ Angiolillo… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction Non-ST-segment elevation acute coronary syndromes (NSTE-ACS), including
non-ST-segment-elevation myocardial infarction (NSTEMI) and unstable angina, represent a …

Questions and answers on antithrombotic therapy and revascularization strategies in non-ST-elevation acute coronary syndrome (NSTE-ACS): a companion …

E Barbato, J Mehilli, D Sibbing… - European heart …, 2021 - academic.oup.com
The content of these European Society of Cardiology (ESC) Guidelines has been published
for personal and educational use only. No commercial use is authorized. No part of the ESC …

Role of Antiischemic Agents in the Management of Non‐ST Elevation Acute Coronary Syndrome (NSTE‐ACS)

M El‐Kadri, H Sharaf‐Dabbagh… - Cardiovascular …, 2012 - Wiley Online Library
Non‐ST elevation acute coronary syndrome (NSTE‐ACS) is the commonest acute
presentation of coronary artery disease (CAD). Mortality and morbidity of the condition has …

Current management of non-ST-segment-elevation acute coronary syndrome: reconciling the results of randomized controlled trials1

A Prasad, V Mathew, DR Holmes Jr… - European heart …, 2003 - academic.oup.com
Aims Patients presenting with non-ST-segment-elevation acute coronary syndrome
represent a heterogeneous group with regard to the severity of coronary atherosclerosis and …

Predictors of long-term use of evidence-based therapies after non-ST-segment elevation acute coronary syndrome. The S-Témoin survey

N Danchin, F Diévart, JF Thébaut, O Grenier… - International journal of …, 2009 - Elsevier
BACKGROUND: We evaluated correlates of prolonged use of evidence-based therapies in
patients discharged after non-ST-segment elevation acute coronary syndrome (NSTE ACS) …

The 'Ten Commandments' for the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment …

JP Collet, H Thiele - 2020 - academic.oup.com
The 2020 ESC Guidelines for the management of acute coronary syndromes in patients
presenting without persistent ST-segment elevation (NSTE-ACS) were developed by the …

Updates and current recommendations for the management of patients with non–ST-elevation acute coronary syndromes: what it means for clinical practice

G Cayla, J Silvain, JP Collet, G Montalescot - The American Journal of …, 2015 - Elsevier
The American Heart Association (AHA) and the American College of Cardiology (ACC) have
recently updated their joint guidelines for the management of patients with non–ST-elevation …

Comparative efficacy and safety of oral P2Y12 inhibitors after non-ST-elevation acute coronary syndromes: a network meta-analysis

IT Farmakis, S Zafeiropoulos, I Doundoulakis… - Open …, 2022 - openheart.bmj.com
Background Currently, potent P2Y12 inhibition with the use of prasugrel or ticagrelor is the
mainstay of treatment after an acute coronary syndrome (ACS). The 2020 European Society …

[HTML][HTML] Compliance of pharmacological treatment for non-ST-elevation acute coronary syndromes with contemporary guidelines: influence on outcomes

H Dores, C Aguiar, J Ferreira, J Mimoso… - Cardiovascular …, 2014 - ncbi.nlm.nih.gov
Background Although the proven efficacy of evidence-based therapy in patients with
cardiovascular diseases, the recommendations are not always instituted. We aimed to …

Questions and answers on diagnosis and risk assessment: a companion document of the 2015 ESC Guidelines for the management of acute coronary syndromes in …

Authors:, C Mueller, C Patrono… - European heart …, 2016 - academic.oup.com
† Full text document: Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, Bax
JJ, Borger MA, Brotons C, Chew DP, Gencer B, Hasenfuss G, Kjeldsen K, Lancellotti P …